SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

ASBP

Aspire Biopharma Holdings Inc.
NASDAQHealth Care

Latest close: 8.78 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Sep 29, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Sep 9, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Sep 8, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year243
SEC filings on record21115 flagged findings
Reported transactions (Form 4)5since May 18, 2023 · and 2 other holdings
Corporate events (8-K)30since Feb 21, 2025

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

Identity

Formerly traded as PWUP.

Reverse splits in 5 years

2 reverse splits in 5 years (1:40 on Jan 16, 2026, 1:30 on May 11, 2026) · 1:1200 cumulative

The other times: of 247 securities that repeated a reverse split in 5 years, a year later the median was worth 0.10× the price on the day of the split; 189 lost more than half and 21 rose (243 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 211)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Sep 29, 268-K ↗Current report · Auditor change filing (8-K Item 4.01)
  • Sep 9, 268-K ↗Current report · Bylaws or fiscal year change · Other events
  • Sep 8, 268-K ↗Current report · Communication to the market
  • Aug 19, 268-K ↗Current report · Communication to the market
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · amendment
  • Aug 13, 2610-Q ↗Quarterly report
  • Aug 10, 268-K ↗Current report · Entered a material agreement
  • Aug 10, 26SCHEDULE 13G ↗Passive stake · GARY SHIRINYAN · 7.7% · event on Jun 17, 26
  • Aug 6, 26SCHEDULE 13G/A ↗Passive stake · Lance Friedman · 7.9% · event on Aug 4, 26 · amendment
  • Jul 20, 268-K ↗Current report · Other events
  • Jul 2, 26SCHEDULE 13G ↗Passive stake · Rubenbauer Alois Ryan III · 5.0% · event on Jun 25, 26
  • Jun 22, 268-K ↗Current report · Shareholder vote results
  • Jun 12, 268-K ↗Current report · Other events
  • Jun 12, 268-K ↗Current report · Entered a material agreement
  • May 15, 2610-Q ↗Quarterly report
  • May 15, 26SCHEDULE 13G ↗Passive stake · Highbridge Capital Management, LLC · 5.2% · event on Mar 31, 26
  • May 14, 268-K ↗Current report · Bylaws or fiscal year change
  • May 13, 26SCHEDULE 13G/A ↗Passive stake · amendment
  • May 8, 26DEF 14A ↗Shareholder meeting and votes
  • Apr 27, 26PRE 14A ↗Shareholder meeting and votes
  • Apr 20, 268-K ↗Current report · Communication to the market
  • Apr 17, 268-K/A ↗Current report · Entered a material agreement · amendment
  • Apr 16, 268-K ↗Current report · Entered a material agreement
  • Apr 16, 268-K ↗Current report · Shareholder vote results
  • Apr 16, 268-K ↗Current report · Communication to the market

211 filings on record, the oldest from Apr 12, 21.

Listing the 25 most recent filings of the 211 on record.

8-Ks, explained

Stress2Structure46Governance12
  • Sep 29, 26GovernanceAuditor change filing (8-K Item 4.01)+1 more in the same filing8-K 4.01 ↗
  • Structure7 material agreements entered2026show all 7hide
    • Aug 10, 26StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
    • Jun 12, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Apr 17, 26StructureEntered a material agreement+2 more in the same filing8-K/A 1.01 ↗
    • Apr 16, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Apr 15, 26StructureEntered a material agreement8-K 1.01 ↗
    • Feb 12, 26StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
    • Jan 30, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jan 15, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jan 13, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jan 6, 26StructureSold unregistered shares+2 more in the same filing8-K 3.02 ↗
  • Nov 14, 25StructureTook on a new financial obligation+4 more in the same filing8-K 2.03 ↗
  • Oct 17, 25StressListing notice (8-K 3.01)+1 more in the same filing · nominal item 3.01: the filing covers another matter8-K 3.01 ↗
  • Sep 26, 25StructureSold unregistered shares+2 more in the same filing8-K 3.02 ↗
  • Aug 22, 25StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Jul 30, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jun 10, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Apr 30, 25StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗

2 older filings not shown · The record reaches back to Feb 23, 22.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Apr 18, 25StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗

The full record holds 2 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

show one more holderhide
  • Harraden Circle Investments, LLC0.3%Mar 31, 25SCHEDULE 13G/A ↗7 co-filers on this document — the figure is the largest single stake, not their sum.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Jun 5, 25Buy$4KDonald G. Fell↗
  • Jun 4, 25Buy$4KDonald G. Fell↗
  • Aug 18, 23Sellamount n/aPowerUp Sponsor LLC↗
Stock compensation, tax and giftsshow the other transactionhide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • May 18, 23Otheramount n/aPowerUp Sponsor LLC↗

The full record holds 4 transactions and goes back to May 18, 23.

Its sector and its market

Aspire Biopharma Holdings Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Aspire Biopharma Holdings Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Aspire Biopharma Holdings Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
211 documents on file, from Apr 12, 2021 to Sep 29, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.

Aspire Biopharma Holdings Inc. (ASBP): stock price history, insider trades and SEC filings — HornScout